PGT-A Chromosomal Screening in Chennai | Smarter Embryo Selection

PGT-A (Preimplantation Genetic Testing for Aneuploidy) is an advanced genetic screening test performed during an IVF cycle to assess the chromosomal health of embryos before transfer. It helps identify embryos with the correct number of chromosomes, supporting informed treatment decisions.

At Agam Fertility and Women Centre, we recommend PGT-A only when it is appropriate for your fertility journey. Our specialists combine advanced reproductive technology with personalized care to help improve embryo selection and support your path to parenthood.

What is PGT-A?

PGT-A is a genetic test performed on embryos created through IVF to check for chromosomal abnormalities before embryo transfer. A few cells are carefully collected from the developing embryo and analyzed in a specialized laboratory to evaluate its chromosomal profile, helping fertility specialists select embryos with a normal chromosomal complement for transfer.

Purpose

Why is PGT-A Performed?

Every IVF journey is unique. While many patients achieve success without genetic testing, others may benefit from additional information before embryo transfer. Rather than increasing the number of embryos, PGT-A focuses on improving the information available when choosing which embryo to transfer.

Evaluate the chromosomal health of embryos

Support more informed embryo selection

Reduce the likelihood of transferring embryos with chromosomal abnormalities

Better understand previous unsuccessful IVF cycles

Guide treatment planning for future embryo transfers

Support personalized fertility care

Candidacy

Who May Benefit from PGT-A?

PGT-A may be recommended for individuals or couples with specific fertility concerns. A detailed fertility consultation helps determine whether it is appropriate for your individual treatment plan.

Have experienced multiple unsuccessful IVF cycles

Have a history of recurrent miscarriage

Are of advanced maternal age

Have produced multiple embryos during IVF

Have experienced repeated implantation failure

Previous pregnancy affected by chromosomal abnormalities

Wish to understand embryo chromosomal health before transfer

Recommendations

When is PGT-A Recommended?

PGT-A is typically considered in situations where additional genetic information may help guide embryo selection and treatment planning.

Recurrent Pregnancy Loss

When repeated miscarriages may be associated with chromosomal abnormalities.

Repeated IVF Failure

To evaluate whether embryo chromosomal status may be contributing to unsuccessful implantation.

Advanced Maternal Age

As maternal age increases, the likelihood of chromosomal abnormalities in embryos also rises.

Multiple Embryos Available

To support informed selection when several embryos are available for transfer.

Previous Chromosomal Concerns

When there is a history of chromosomal abnormalities identified in previous pregnancies or fertility treatments.

Process

How Does PGT-A Work?

PGT-A is integrated into an IVF cycle and involves several carefully coordinated stages.

1

IVF & Embryo Development

Eggs are collected through IVF and fertilized in the laboratory. The embryos are cultured under controlled conditions until they reach the blastocyst stage.

2

Embryo Biopsy

A small number of cells are gently removed from the outer layer of the embryo. These cells are used for genetic analysis without disturbing the portion that develops into the baby.

3

Genetic Testing

The biopsied cells are examined using advanced genetic testing techniques to determine whether the embryo has the correct number of chromosomes.

4

Embryo Cryopreservation

While the genetic analysis is completed, the embryos are safely preserved using vitrification.

5

Embryo Transfer

Based on the test results and your clinical evaluation, your fertility specialist recommends the most appropriate embryo for transfer in a subsequent cycle.

Every stage is performed with precision to support safe laboratory practices and informed clinical decision-making.

Advantages

Benefits of PGT-A

For suitable patients, PGT-A can provide valuable insights during fertility treatment. The benefits of PGT-A depend on individual medical circumstances, making specialist evaluation essential before treatment.

More informed embryo selection

Better understanding of embryo chromosomal health

Personalized treatment planning

Reduced likelihood of transferring abnormal embryos

Improved confidence during transfer decisions

Valuable information following previous IVF failures

Supports evidence-based fertility care

Evaluation

Is PGT-A Right for Everyone?

No.

PGT-A is not routinely recommended for every IVF patient. While it can provide important genetic information, the decision to undergo testing depends on factors such as age, fertility history, embryo development, and previous treatment outcomes.

At Agam, we recommend PGT-A only when there is a clear clinical benefit. Every patient receives individualized guidance to ensure that treatment decisions are appropriate, ethical, and aligned with their reproductive goals.

Agam Difference

Why Choose Agam for PGT-A?

Advanced fertility care is about more than technology it is about making the right decisions at the right time. At Agam Fertility and Women Centre, PGT-A is integrated into a personalized fertility plan designed around your individual medical needs. Our team combines advanced reproductive science with thoughtful clinical evaluation to help patients navigate complex fertility journeys with confidence and clarity.

Personalized fertility treatment planning & experienced specialists

Comprehensive reproductive evaluation & individualized transfer planning

Advanced embryology and genetics support

Evidence-based clinical recommendations & ethical medical practices

Transparent patient care & compassionate guidance throughout your journey

Support

Frequently Asked Questions

PGT-A evaluates whether an embryo has the correct number of chromosomes before embryo transfer. It helps identify embryos with chromosomal abnormalities that may affect implantation or pregnancy.

No. PGT-A is not a fertility treatment by itself. It is an additional genetic screening procedure performed during an IVF cycle.

No. PGT-A does not guarantee pregnancy. It provides valuable genetic information that helps fertility specialists make more informed embryo selection decisions. Pregnancy success also depends on several other factors, including embryo quality, uterine health, maternal age, and overall reproductive health.

Embryo biopsy is performed by trained embryologists using specialized laboratory techniques. Your fertility specialist will discuss whether PGT-A is suitable for your treatment.

No. PGT-A is recommended only for selected patients based on their medical history, fertility condition, and treatment goals.

Some miscarriages are associated with chromosomal abnormalities. For selected patients, PGT-A may help identify embryos with a normal chromosomal profile, which can support more informed treatment planning.

Informed Decisions Begin with the Right Information

Every fertility journey is unique, and every treatment decision deserves careful consideration. PGT-A provides valuable genetic insights that can help guide embryo selection and support a more personalized IVF journey. At Agam Fertility and Women Centre, we're committed to combining advanced reproductive science with compassionate care, helping you move forward with confidence, clarity, and hope.

Book Your Consultation

PGT-A Testing